SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001711279-23-000064
Filing Date
2023-08-07
Accepted
2023-08-07 07:07:31
Documents
60
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q krys-20230630.htm   iXBRL 10-Q 1158402
2 EX-31.1 krys-20230630ex311.htm EX-31.1 10684
3 EX-31.2 krys-20230630ex312.htm EX-31.2 10647
4 EX-32.1 krys-20230630ex321.htm EX-32.1 11156
  Complete submission text file 0001711279-23-000064.txt   5971475

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20230630.xsd EX-101.SCH 36143
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT krys-20230630_cal.xml EX-101.CAL 53026
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT krys-20230630_def.xml EX-101.DEF 151469
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20230630_lab.xml EX-101.LAB 556113
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20230630_pre.xml EX-101.PRE 345781
54 EXTRACTED XBRL INSTANCE DOCUMENT krys-20230630_htm.xml XML 918296
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38210 | Film No.: 231145564
SIC: 2836 Biological Products, (No Diagnostic Substances)